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Abstract
Background: An estimated 285 million people worldwide have diabetes and its prevalence is predicted to increase
to 439 million by 2030. For the year 2010, it is estimated that 3.96 million excess deaths in the age group 20-79
years are attributable to diabetes around the world. Self-management is recognised as an integral part of diabetes
care. This paper describes the protocol of a randomised controlled trial of an automated interactive telephone
system aiming to improve the uptake and maintenance of essential diabetes self-management behaviours.
Methods/Design: A total of 340 individuals with type 2 diabetes will be randomised, either to the routine care
arm, or to the intervention arm in which participants receive the Telephone-Linked Care (TLC) Diabetes program in
addition to their routine care. The intervention requires the participants to telephone the TLC Diabetes phone
system weekly for 6 months. They receive the study handbook and a glucose meter linked to a data uploading
device. The TLC system consists of a computer with software designed to provide monitoring, tailored feedback
and education on key aspects of diabetes self-management, based on answers voiced or entered during the
current or previous conversations. Data collection is conducted at baseline (Time 1), 6-month follow-up (Time 2),
and 12-month follow-up (Time 3). The primary outcomes are glycaemic control (HbA1c) and quality of life (Short
Form-36 Health Survey version 2). Secondary outcomes include anthropometric measures, blood pressure, blood
lipid profile, psychosocial measures as well as measures of diet, physical activity, blood glucose monitoring, foot
care and medication taking. Information on utilisation of healthcare services including hospital admissions,
medication use and costs is collected. An economic evaluation is also planned.
Discussion: Outcomes will provide evidence concerning the efficacy of a telephone-linked care intervention for
self-management of diabetes. Furthermore, the study will provide insight into the potential for more widespread
uptake of automated telehealth interventions, globally.
Trial Registration Number: ACTRN12607000594426
Background
Diabetes is a leading cause of death and morbidity and
is a health priority in Australia and worldwide. Over 285
million people have diabetes around the world [1] (90%
of whom are diagnosed with type 2 diabetes). For the
year 2010, it is estimated that 3.96 million excess deaths
in the age group 20-79 years are attributable to diabetes
around the world [2]. The number of people living with
diabetes is predicted to reach 439 million in 2030 [1].
Poor glycaemic control, as measured by Haemoglobin
A1c (HbA1c), significantly increases one’s risk of costly
diabetes-related complications [3,4].
Self-management is an integral component of effective
diabetes care [5]. Systematic reviews of interventions
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targeting diabetes self-management indicate that the
effectiveness of these programs is significantly related to
their duration [6,7]. This emphasises the importance of
ongoing follow-up and support for successful long-term
glycaemic control [8].
The delivery of ongoing support to the fast growing
number of people living with diabetes presents a real
challenge for most health systems and this will not be
addressed by any modest increase in the number of rele-
vant health professionals to provide such services.
Addressing this challenge requires new cost-effective
approaches that will reach a large number of individuals
regularly, in particular, those people who already have
poor access to current services, due to geographical,
financial or other barriers.
Programs using automated information and telecom-
munication technologies offer a potential solution to
chronic disease management as they can be conveni-
ently accessed from home or office and at any time of
the day or night. Reviews of such interactive automated
technologies in chronic disease care, including diabetes
[9-11], report positive effects on users’ self-care knowl-
edge, clinical and behavioural outcomes, social support
and health care utilisation. In addition, acceptability of
automated telephone programs among users has been
shown to be high [12]. Further, the logical structure, on
which computerised interventions are built, means that
they offer a consistency of delivery which is difficult to
achieve in programs delivered by health professionals.
Therefore, these technologies hold promise as a new
approach to overcome barriers associated with the tradi-
tional delivery of chronic disease self-management pro-
grams by offering effectiveness, accessibility and
consistency. They may also prove to be cost-effective.
The use of a telephone as the mode of access to these
programs makes them available to the majority of the
population. The Telephone-Linked Care (TLC) system
is an interactive computer assisted telephone system
which has been shown to improve health behaviours
and to be acceptable to users [13-17]. This system con-
sists of a computer connected to the telephone network,
equipped with speech recognition, numerous pre-
recorded conversation statements and a database in
which users’ answers are stored. It is designed to emu-
late telephone conversations between patients and
health professionals. It tailors its responses, including
feedback and encouragement, according to data entered
in the TLC database and the answers that it receives
during the current and previous calls.
This paper presents the study protocol for a rando-
mised controlled trial (RCT) of a TLC system aiming to
improve type 2 diabetes management, TLC Diabetes.
We hypothesise that participants in the intervention
arm will demonstrate greater improvements in HbA1c
and health-related quality of life (QoL) compared to
those in the control arm. Secondly, we hypothesise that
the intervention will be cost-effective compared with the
control arm. The results of this study will provide valu-
able information about the efficacy, cost-effectiveness,
acceptability and feasibility of a novel way to improve
type 2 diabetes self-management.
Methods/design
Study design
The study is a two-arm prospective RCT in which a
total of 340 adults with type 2 diabetes will be rando-
mised to either the intervention (TLC Diabetes pro-
gram) or ‘routine care’ control arm. Participants in both
arms complete assessments at baseline (Time 1),
6-month follow-up (Time 2), and 12-month follow-up
(Time 3).
Study aims
Primary Aim: To investigate the effects of the TLC Dia-
betes program on health outcomes (primary outcome
variables include HbA1c and QoL measured using the
Short Form-36 version 2 [SF-36v2]) post intervention
(Time 2) and at 12- month follow-up (Time 3).
Secondary Aim: To examine the cost-effectiveness of
the intervention arm in comparison with the control
arm.
Study sample
Eligibility criteria
Eligibility criteria include: a type 2 diabetes diagnosis of
at least 3 months; aged 18 - 70 years; residing in the
greater Brisbane area (Australia); an HbA1c level of at
least 7.5%; stable diabetes pharmacotherapy type for at
least 3 months; stable pharmacotherapy dosage for at
least 4 weeks; ability to clearly speak and understand
English via the telephone, and weekly access to a tele-
phone. Participants are excluded if they are: diagnosed
with a condition with likely poor prognosis within 1
year; diagnosed with dementia or a psychiatric co-mor-
bidity; pregnant, lactating, or planning to become preg-
nant within the next 12 months; currently enrolled in
another intervention trial; or have undergone bariatric
surgery in the past 2 years.
Sample recruitment procedures
A range of recruitment strategies are used including
advertisements in newspapers and community newslet-
ters and distribution of flyers to a large number of
health professionals to provide to patients diagnosed
with type 2 diabetes. Patients of diabetes clinics of three
major hospitals in Brisbane and clients of Diabetes
Australia - Queensland’s shops and information semi-
nars are also informed of the study by research staff or
by flyers placed in reception areas.
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Individuals expressing interest in participating are
screened in two stages. They are firstly assessed against
eligibility criteria at first contact via telephone or in per-
son. If deemed potentially eligible, they attend a baseline
appointment at one of two large teaching hospitals, the
Princess Alexandra Hospital (PAH) or the Royal
Brisbane and Women’s Hospital (RBWH) in Brisbane,
where they are provided with a comprehensive explana-
tory statement. After signing the study consent form,
they complete the baseline questionnaires and a hospital
phlebotomist takes the blood specimens required. They
are excluded if the HbA1c result from this blood test
does not meet the HbA1c criterion.
Sample size calculations
A total of 340 eligible participants will be recruited to
the study. It is anticipated that there will be an attrition
rate of up to 30% over the 12 months of follow-up, so
we expect complete data on 238 participants. With 238
completing participants, we shall be able to detect, with
90% power and type I error of 5% (two-tailed), excess
intervention effects over routine care effects of at least
0.4% (from baseline 8.9% to 8.5%) in HbA1c. The calcu-
lations for HbA1c were based on standard deviations of
change of 1% in both groups, conservatively estimated
assuming maximum physiological range of 3% improve-
ment or deterioration of individuals. An effect size of
0.4% in our primary outcome, HbA1c, was chosen for
our sample size calculations as per Toobert [18], who
calculated that a change of 0.4% translates into a clini-
cally meaningful 14% reduction in risk of diabetes com-
plications based on the analysis of the UK Prospective
Diabetes Study in patients with type 2 diabetes. For SF-
36v2 physical and mental component summary scores, a
sample of 238 completed participants has 90% power to
detect a difference of 3.9 units (assuming standard
deviation of 10 [19]).
Ethics approval
Ethics approval was received from Human Research
Ethics Committees of the Princess Alexandra Hospital
(No. 2007/029), Royal Brisbane and Women’s Hospital
(No. HREC/09/QRBW/21), Prince Charles Hospital
(No. HREC/O9/QPC HJ26), the University of Queens-
land (No. 2007000899) and Monash University (No.
CF07/0313 - 2007/0102).
Study arms
All participants receive a quarterly newsletter consisting
of general health information; this aims to maintain
participation.
Control arm
Control participants are advised to continue their rou-
tine medical care.
Intervention arm
Intervention participants also continue their routine
medical care. In addition, they receive the TLC Diabetes
program which was developed collaboratively between
the Australian research team and USA researchers at
the Medical Information Systems Unit, Boston Univer-
sity [20,21]. The TLC Coordinator, whose role is to sup-
port intervention group participants in all aspects of use
of the TLC Diabetes program, meets with participants
within one week of their Time 1 data collection to pro-
vide them with the TLC Diabetes kit containing the
TLC Handbook, an ACCU-CHEK® Advantage glucose
meter, test strips, and a Bluetooth™ device with which to
upload their blood glucose results to the TLC Diabetes
system. The TLC Handbook contains instructions and
general information on the TLC Diabetes program, a
number of Diabetes Australia diabetes management fact
sheets plus sheets on which to record notes and infor-
mation related to the program. A quit smoking informa-
tion pack, containing a self-help booklet and brochures,
is also provided to current smokers. During this meet-
ing, participants also receive instructions on how to
operate the glucose meter and the uploading Bluetooth™
device and complete a training call to the TLC Diabetes
system. Participants are asked to perform all blood glu-
cose self-monitoring with the study glucose meter and
to upload its readings immediately preceding their
weekly telephone conversations with the TLC system.
Participants choose a unique personal password which
they enter at the start of each call to the system and
which is linked to their database file and ensures correct
subject identification and confidentiality. Prior to the
participants’ first call to the system the TLC Coordina-
tor obtains personalised self-care clinical targets for the
participants from their primary health care provider.
This includes recommended number of daily blood glu-
cose tests, ideal fasting blood glucose range and clear-
ance for physical activity. Once this information is
entered into the database, participants start making
weekly calls to the system over a period of 24 weeks.
The calls are at no cost to them and they can last
between 5 and 20 minutes (depending upon the content
of the call and the participant’s responses). Blood glu-
cose monitoring is the first topic covered in each weekly
call. It is followed by one of the following topics: medi-
cation-taking (calls 1-4; 13-16), physical activity (calls
5-8; 17-20), and healthy eating (calls 9-12; 21-24). When
a participant does not take any medication prescribed
for diabetes, the medication-taking topic is replaced by
physical activity. When the treating physician does not
provide clearance for physical activity, this topic is
replaced by medication-taking. In cases when there is
no clearance for physical activity and no pharmaceutical
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treatment of diabetes, the participant does not hear a
second topic on calls 1-8, and 13-20.
The TLC Coordinator phones participants after their
first two calls to the TLC system and at weeks 6, 12 and
20, to identify and resolve any issues faced during their
use of the TLC Diabetes system or to identify reasons
for not calling regularly. Additionally, the TLC Diabetes
system sends email “alerts” to a dedicated project email
address to signal the need for the Coordinator to con-
tact a participant regarding technical or other issues.
Study integrity
The study design is according to the recommendations
of the CONSORT statement for randomised trials of
non-pharmacologic treatment [22]. Randomisation to an
experimental group occurs after the Time 1 baseline
assessment is completed. Arm allocation is conducted
using a 4 × 4 block randomised block design with the
participant as the unit of randomisation. Due to the
complex nature of the intervention, it is not possible to
blind research staff to group allocation. The intervention
protocol is documented and the data generated during
the calls made by participants is stored in the TLC data-
base. All analyses will be conducted based on the princi-
ple of intention to treat.
Measurement
All assessments (Table 1) are administered at the PAH
or RBWH but at the same location for Time 1, 2 and 3.
Blood specimens are collected according to Queensland
Health guidelines. Waist and hip circumferences are
measured according to WHO MONICA guidelines [23].
Behaviour, psychosocial and health care utilisation
(HCU) questionnaires are self-administered.
Primary and secondary outcome variables
Primary outcome variables are: HbA1c and health-related
QoL measured by the SF-36v2 [24,25]. Secondary outcome
variables include: clinical measures (blood lipid profile,
body mass index [BMI], waist and hip circumferences,
blood pressure), psychosocial outcomes (depression and
anxiety symptoms [26], social support [27]), nutrition and
physical activity self-efficacy [28], physical activity [29],
diet [30], adherence to foot-care, medication taking and
blood glucose testing [31]. Information pertaining to HCU
(visits to health practitioners, hospital admissions, other
hospital services and medications), healthcare costs and
costs of the intervention is also collected. The measures
for these variables are summarised in Table 1.
Intervention implementation
Adherence to the program is assessed by the proportion
of completed calls to the system relative to the expected
Table 1 Primary and secondary outcome measures for times 1, 2 and 3
Variable Instrument
Primary outcome variables
Glycaemic control HbA1c
Quality of life SF-36v2 [24,25]
Secondary outcome variables
Blood lipids Total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides
Insulin sensitivity HOMA score
Kidney function Creatinine and estimated Glomerular Filtration Rate (e-GFR)
Blood pressure Measured twice using Welch-Allyn electronic sphygmomanometer on same arm. A third
measure is taken when the first two readings differ by more than 10 mmHg and 6mmHg
for systolic and diastolic blood pressure respectively.
Body Mass Index (BMI) Calculated from height and weight measured by research staff
Waist and hip circumference Measured by research staff according to WHO MONICA project guidelines [23]
Diet Anti Cancer Council of Victoria Food Frequency Questionnaire [30] (ACCVFFQ)
Physical activity Active Australia Survey [29]
Self-efficacy (nutrition and physical activity) Self-efficacy scales [28]
Anxiety and depression Hospital Anxiety and Depression Scale [26]
Social support ENRICHD Social Support Inventory [27]
Smoking Self-report
Adherence to recommendations for blood glucose
testing, foot-care and medication
Summary of Diabetes Self-Care Activities [31]
Health care service utilisation, except hospital
admissions
Self-report for visit to health professionals, usage of hospital services not involving
admissions and medications
Hospital admissions Electronic records maintained by Queensland Health, plus self-report for admissions to
private hospitals
Co-morbidities Self-report
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number of calls, time interval between calls, and call
duration. In addition, satisfaction with and perception of
usefulness of the intervention are assessed by self-
administered questionnaire at Time 2 and a semi-
structured interview at Time 3.
Socio-demographic variables
Self-reported socio-demographic variables include gen-
der, age, ethnicity, marital status, education, employ-
ment status, private health insurance status and
household income.
Data analyses
Assessment of similarity of baseline characteristics
across randomised groups will be performed using
appropriate summary statistics. If any imbalances of
characteristics between the two groups are identified,
these will be adjusted for in the main analytical model-
ling as supplementary analyses. Evaluation of the TLC
Diabetes intervention effect will be based on an inten-
tion-to-treat analysis. Analysis of covariance (with base-
line score as the covariate) will be fitted to estimate
differences by intervention group in changes over time
at each time point. Analysis across all time points using
all available data, including as much as possible those of
participants lost to follow-up, will employ generalised
estimating equations. Results will be expressed as esti-
mated mean changes in primary and other outcome
variables by group, and as overall mean excess interven-
tion over routine care effects, all with corresponding
95% confidence intervals.
Cost-effectiveness analysis
Detailed economic data will be collected throughout the
trial to enable a comprehensive evaluation of the inter-
vention’s efficiency when compared to routine care. Data
on HCU will be obtained from participants at times 1, 2
and 3 and data on all public hospital admissions will be
obtained from Queensland Health. Standard costs will be
applied to HCU in both arms (e.g. Australian-Revised
Diagnostic Related Groups for hospital admission costs).
The intervention arm will also incur the costs of the
intervention including set-up costs that will be annuitized
(e.g. computer, telephone line connections) and operating
costs (e.g. TLC Coordinator).
Within-trial and modelled over the rest of life cost-
utility analyses will be undertaken from the perspective
of direct health care costs to the government. SF-36v2
scores will be converted to utility weights using the SF-6
D algorithm [32] for the calculation of quality-adjusted
life years (QALYs) - the primary outcome for the eco-
nomic evaluation. The incremental costs and QALYs
will be calculated as the differences between participants
in the intervention and routine care groups. The result-
ing incremental cost-utility ratio will provide a measure
of the relative value for money of the intervention using
the additional cost per QALY gained. One-way and
probabilistic sensitivity analyses will be undertaken for
all parameters with uncertainty and/or variability [33].
Discussion
Previous trials of automated TLC systems targeting phy-
sical activity, nutrition and medication adherence have
demonstrated the effectiveness of such technology to
improve health behaviours and chronic disease self-
management [13,16,17]. To date, this innovative and
accessible form of self-management support program
has not been formally tested in relation to diabetes man-
agement and its cost-effectiveness has not been exam-
ined. Therefore, this study will provide valuable
information on the effectiveness, user-acceptability and
feasibility of this telehealth system. It addresses the need
to investigate new approaches to deliver ongoing and
regular diabetes self-management support to relieve
health systems from the growing demands caused by the
increasing prevalence of diabetes around the world.
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